* DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in
quarterly revenue when it reports results on March 13.
* The New York City-based company is expected to report a
14.4% decrease in revenue to $103.824 million from $121.3
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for DocGo Inc is for
earnings
of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for DocGo Inc
is
$13, above its last closing price of $8.55.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.05 0.05 0.03 Missed -33.3
Jun. 30 2022 0.04 0.04 0.11 Beat 200
Mar. 31 2022 0.05 0.05 0.09 Beat 66.7
Dec. 31 2021 0.02 0.02 0.23 Beat 1,050
Sep. 0.00 0.00 0.04 Beat
30 2021
This summary was machine generated March 11 at 00:40 GMT. All
figures in US dollars unless otherwise stated